ReviewThe journal of headache and pain2025
Hallmarks of primary headache: part 4 - rare headache syndromes.
Review in The journal of headache and pain, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aim“Other primary headaches” is a group of heterogeneous headache disorders described in Chapter 4 of the third edition of the International Classification of Headache Disorders (ICHD-III). Due to the limited number of cases, most of these disorders are considered rare and represent a diagnostic and therapeutic challenge for clinicians and headache specialists. To increase knowledge, improve their recognition, and foster research on these rare headache disorders, this review provides a comprehensive up-to-date description of their hallmarks, including epidemiologic data, key clinical characteristics, proposed pathophysiological mechanisms, and suggested treatments. PRINCIPAL
findingsDiagnosing rare headache disorders is challenging. A few key clinical features can help improve their recognition and distinction. These include identifying a specific trigger or stimulus for headache development such as cough, exercise, or sexual activity, a particular pattern of onset or recurrence, like for hypnic headache, primary thunderclap headache, or new daily persistent headache, or a unique scalp location for the pain such as for nummular headache or epicrania fugax. These clinical details are crucial for narrowing the differential diagnosis and making the correct diagnosis. However, regardless of the specificity of the clinical presentation, secondary causes must be ruled out when facing patients with these rare clinical presentations. Limited evidence on the pathophysiology and treatment of these disorders is available, and high-quality studies are lacking.
conclusionsAccurate diagnosis and additional research on these rare headache disorders are needed. Multicenter and international collaborations within the framework of international headache societies and among tertiary headache centers are key to developing efficient and high-quality registries and databases. Additionally, clinical trials are needed to develop evidence supporting the treatments current in use and to address the unmet needs of these rare diseases. Only through these efforts it will be possible to design specific studies to increase our understanding of these rare disorders and improve the quality of life of individuals living with these conditions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.